ArticleClinical, cosmetic and investigational dermatology2026
Exploring the Toxicological Impact of Bisphenol A on Acne Vulgaris via the PLA2G2A-Arachidonic Acid Pathway.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the potential molecular mechanisms underlying the contribution of environmental bisphenol A (BPA) exposure to acne pathogenesis, with a specific focus on the PLA2G2A-arachidonic acid pathway. Methods: We integrated network toxicology and machine learning to identify common target genes linking BPA exposure and acne. Core genes and key pathways were screened through differential expression, gene enrichment, and feature selection algorithms. The findings were validated in independent datasets and further investigated using immune infiltration analysis, molecular docking, and molecular dynamics simulations. Results: Three core genes were identified, with PLA2G2A being the central hub. Functional enrichment analysis revealed significant involvement of these targets in arachidonic acid metabolism, PI3K-AKT signaling, and IL-6/JAK-STAT3 pathways. PLA2G2A was upregulated in acne lesions and positively correlated with pro-inflammatory immune cell infiltration. Molecular docking and dynamics simulations indicated stable binding between BPA and PLA2G2A. Conclusion: These findings suggest that BPA exposure may contribute to acne development by targeting PLA2G2A, disrupting arachidonic acid metabolism, and modulating the local inflammatory microenvironment. Crucially, this study highlights the environmental risk of endocrine-disrupting chemicals in dermatology and identifies PLA2G2A as a novel, potential therapeutic target for comprehensive acne management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.